Alan Smith, is currently the Executive Vice President Technical Operations at Bellicum Pharmaceuticals. He has broad experience in the cell therapy area with over 30 years working in various senior management roles in research and development, manufacturing and quality in cell and gene therapy companies. Prior to joining Bellicum, Dr. Smith held senior management positions at LifeNet Health, Cognate BioServices, Aastrom Biosciences, Geneic Sciences, Baxter Healthcare, BioSpecific Technologies and HyClone also as President of his own consulting company in the industry. Dr. Smith earned his BS degree in Chemistry at Southern Utah University and his doctorate in Biochemistry at Utah State University.
The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.